Title:
HEART DISEASE AGENT AND METHOD FOR IMPROVING HEART DISEASE
Document Type and Number:
WIPO Patent Application WO/2023/033166
Kind Code:
A1
Abstract:
[Problem] To provide a heart disease agent that is safe even when ingested over a long period of time and that can effectively improve heart disease. [Solution] Nicotinamide mononucleotide is an active component.
Inventors:
TANAKA MEGUMI (JP)
TANAKA TSUNEMARU (JP)
TANAKA TSUNEMARU (JP)
Application Number:
PCT/JP2022/033223
Publication Date:
March 09, 2023
Filing Date:
September 05, 2022
Export Citation:
Assignee:
MIRAILAB BIOSCIENCE INC (JP)
International Classes:
A23L33/13; A61K31/706; A61P9/00; A61P9/04; A61P9/06; A61P9/10
Domestic Patent References:
| WO2019131308A1 | 2019-07-04 |
Foreign References:
| CN113332304A | 2021-09-03 |
Other References:
TAKANOBU YAMAMOTO, JAEMIN BYUN, PEIYONG ZHAI, YOSHIYUKI IKEDA, SHINICHI OKA, JUNICHI SADOSHIMA: "Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion", PLOS ONE, vol. 9, no. 6, 6 June 2014 (2014-06-06), pages 1 - 14, XP055769555, DOI: 10.1371/journal.pone.0098972
BIOORG. MED. CHEM. LETT., vol. 12, 2002, pages 1135 - 1137
CHEM. COMM., 1999, pages 729 - 730
BIOORG. MED. CHEM. LETT., vol. 12, 2002, pages 1135 - 1137
CHEM. COMM., 1999, pages 729 - 730
Attorney, Agent or Firm:
SHIMAZAKI Eiichiro (JP)
Download PDF: